Literature DB >> 849198

Surgical treatment of squamous cell carcinoma of the oral tongue: factors influencing survival.

J O Whitehurst, C A Droulias.   

Abstract

One hundred fifty patients with squamous cell carcinoma of the oral tongue (anterior two thirds) treated initially by surgery alone were analyzed and factors influencing survival were evaluated. Thirteen patients who died without evidence of disease in less than five years were excluded, leaving 137 determinate cases for review. The overall survival was 67.9%. The presence or absence of cervical node metastases appeared to be the most important determining factor in this series. The size of the primary lesion in itself did not play a substantial role in local control. However, overall survival was affected because the larger the primary lesion the higher the incidence of cervical metastases, and therefore, the lower the survival. It is concluded that partial glossectomy is effective treatment for control of localized disease (92.7%). Since cervical node metastases lowered the survival figures to 31%, it appears that more aggressive prophylactic treatment in the form of neck dissection or radiotherapy is indicated for lesions larger than 2 cm.

Entities:  

Mesh:

Year:  1977        PMID: 849198     DOI: 10.1001/archotol.1977.00780210068007

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  9 in total

1.  Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

Authors:  Aditi Bhattacharya; Ritu Roy; Antoine M Snijders; Gregory Hamilton; Jesse Paquette; Taku Tokuyasu; Henrik Bengtsson; Richard C K Jordan; Adam B Olshen; Daniel Pinkel; Brian L Schmidt; Donna G Albertson
Journal:  Clin Cancer Res       Date:  2011-11-08       Impact factor: 12.531

2.  Influence of tumor volume on survival in patients with oral squamous cell carcinoma.

Authors:  Thomas Mücke; David A Mitchell; Lucas M Ritschl; Andrea Tannapfel; Klaus-Dietrich Wolff; Marco R Kesting; Denys J Loeffelbein; Anastasios Kanatas
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-26       Impact factor: 4.553

3.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 4.  Role of (18)F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma.

Authors:  Bundhit Tantiwongkosi; Fang Yu; Anand Kanard; Frank R Miller
Journal:  World J Radiol       Date:  2014-05-28

5.  Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Authors:  R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-12       Impact factor: 3.825

6.  Prognostic impact of preoperative serum interleukin-6 levels in patients with early-stage oral squamous cell carcinoma, defined by sentinel node biopsy.

Authors:  Hiroyuki Goda; Masato Okamoto; Koh-Ichi Nakashiro; Satoshi Hino; Ryuichi Murase; Hiroyuki Hamakawa
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

7.  Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer.

Authors:  Lubos Tuček; Jiri Petera; Igor Sirák; Milan Vošmik; Helena Doležalová; Simona Brokešová; Miroslav Hodek; Linda Kašaová; Petr Paluska
Journal:  Rep Pract Oncol Radiother       Date:  2011-08-06

8.  Analyzing the factors that influence occult metastasis in oral tongue cancer.

Authors:  Jung-Hyun Shin; Hye-Jung Yoon; Soung-Min Kim; Jong-Ho Lee; Hoon Myoung
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-04-30

Review 9.  Is There Still a Place for Brachytherapy in the Modern Treatment of Early-Stage Oral Cancer?

Authors:  Luboš Tuček; Milan Vošmik; Jiří Petera
Journal:  Cancers (Basel)       Date:  2022-01-03       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.